Deciding between Semaglutide and Tirzepatide depends on several factors, including your medical history, weight loss goals, and any underlying health conditions
Figure 8
These may include nausea, mild digestive changes, or fatigue
Common injection sites include: Abdomen Thigh Upper arm Dosing is gradually adjusted based on tolerance and response
The ability of the MD to reduce visceral adiposity while preserving LBM may have important implications in the context of semaglutide therapy, which is known to reduce overall fat but, in some rare cases, also to associate with a LBM loss [68, 69]
Patients with prior recurrent UTIs, spinal cord injury, or neurogenic bladder may warrant closer monitoring or prophylactic measures